Predictions
Novavax Inc.
Start price
Target price
Perf. (%)
€110.70
27.07.20
27.07.20
-
04.11.21
04.11.21
50.84%
05.11.21
05.11.21
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Probably not worthwhile Investment
High valuation
Ipsen S.A.
Start price
Target price
Perf. (%)
€81.00
13.07.20
13.07.20
€95.00
04.11.21
04.11.21
12.32%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Purple Biotech Ltd. ADR
Start price
Target price
Perf. (%)
€7.10
11.07.20
11.07.20
€6.00
04.11.21
04.11.21
-43.38%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Innovative
Good culture
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€70.87
08.06.20
08.06.20
€65.00
04.11.21
04.11.21
-18.67%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€70.87
08.06.20
08.06.20
€65.00
04.11.21
04.11.21
-18.67%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€70.87
08.06.20
08.06.20
€65.00
04.11.21
04.11.21
-18.67%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€131.66
06.06.20
06.06.20
€205.00
04.11.21
04.11.21
77.81%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Nanobiotix
Start price
Target price
Perf. (%)
€8.08
29.05.20
29.05.20
€11.00
04.11.21
04.11.21
9.22%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€18.68
21.05.20
21.05.20
€30.00
04.11.21
04.11.21
531.06%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.08
20.05.20
20.05.20
€4.50
04.11.21
04.11.21
56.99%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Novavax Inc.
Start price
Target price
Perf. (%)
€35.54
12.05.20
12.05.20
€205.00
04.11.21
04.11.21
369.84%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Transgene S.A.
Start price
Target price
Perf. (%)
€1.90
04.05.20
04.05.20
€2.80
04.11.21
04.11.21
21.05%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€77.59
03.05.20
03.05.20
€90.00
04.11.21
04.11.21
-25.71%
05.11.21
05.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€77.59
03.05.20
03.05.20
€90.00
04.11.21
04.11.21
-25.71%
05.11.21
05.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€77.59
03.05.20
03.05.20
€90.00
04.11.21
04.11.21
-25.71%
05.11.21
05.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€76.31
30.04.20
30.04.20
€55.00
04.11.21
04.11.21
-24.47%
05.11.21
05.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€76.31
30.04.20
30.04.20
€55.00
04.11.21
04.11.21
-24.47%
05.11.21
05.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€76.31
30.04.20
30.04.20
€55.00
04.11.21
04.11.21
-24.47%
05.11.21
05.11.21
Supernus Pharmaceuticals
Start price
Target price
Perf. (%)
€21.80
29.04.20
29.04.20
€30.00
04.11.21
04.11.21
25.69%
05.11.21
05.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€77.15
29.04.20
29.04.20
€90.00
04.11.21
04.11.21
-25.29%
05.11.21
05.11.21